Park Square has placed William Hodder as Chief Executive Officer at NFlection Therapeutics, Inc.
NFlection Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare...…
Park Square is pleased to announce the placement of Dr. Robert Gould as an Independent Director at Faeth Therapeutics. Faeth is a...
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic...
Theator, the Surgical Intelligence platform harnessing advanced AI and computer vision technology to tackle variability and disparity in...
The public benefit company, born of a partnership of Boston-area universities, hospitals, and private industry led by Harvard and MIT, ...…
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net